Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 3,772 MIRM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 3,772 | n/a |
| Jun 16, 2026 | Sensei Biotherapeutics, Inc. (FTH) | Grant/Award | 25,000 | n/a |
| Jun 2, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 3,977 | n/a |
| May 19, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 2,000 | $47.0K |
| Apr 23, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 40,485 | n/a |
| Apr 17, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 2,000 | $47.0K |
| Mar 17, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 2,000 | $47.0K |
| Feb 17, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 2,000 | $47.0K |
| Jan 16, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 2,000 | $47.0K |
| Dec 23, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 5,000 | $117.6K |